Literature DB >> 33941198

Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients.

Guangtao Sun1, Kejian Sun1, Chao Shen2.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality in the world.
METHOD: We downloaded the mRNA profiles and clinical information of 371 HCC patients from The Cancer Genome Atlas (TCGA) database. The consensus clustering analysis with the mRNA levels of 48 nuclear receptors (NRs) was performed by the "ConsensusClusterPlus." The univariate Cox regression analysis was performed to predict the prognostic significance of NRs on HCC. The risk score was calculated by the prognostic model constructed based on eight optimal NRs. Then multivariate Cox regression analysis was performed to determine whether the risk score is an independent prognostic signature. Finally, the nomogram based on multiple independent prognostic factors was used to predict the long-term survival of HCC patients.
RESULTS: The prognostic model constructed based on the eight optimal NRs (NR1H3, ESR1, NR1I2, NR2C1, NR6A1, PPARD, PPARG, and VDR) could effectively predict the prognosis of HCC patients as an independent prognostic signature. Moreover, the nomogram was constructed based on multiple independent prognostic factors including risk score and tumor node metastasis (TNM) stage and could better predict the long-term survival for 3- and 5-year of HCC patients.
CONCLUSION: Our results provided novel evidences that NRs could act as the potential prognostic signatures for HCC patients.

Entities:  

Keywords:  HCC; Human nuclear receptors (NRs); Prognosis; Risk score

Year:  2021        PMID: 33941198     DOI: 10.1186/s12957-021-02246-x

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  28 in total

Review 1.  Visualizing the Architectures and Interactions of Nuclear Receptors.

Authors:  Sepideh Khorasanizadeh; Fraydoon Rastinejad
Journal:  Endocrinology       Date:  2016-10-05       Impact factor: 4.736

Review 2.  Nuclear receptor coactivators: master regulators of human health and disease.

Authors:  Subhamoy Dasgupta; David M Lonard; Bert W O'Malley
Journal:  Annu Rev Med       Date:  2013-09-16       Impact factor: 13.739

Review 3.  Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention.

Authors:  Donato F Romagnolo; Janos Zempleni; Ornella I Selmin
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

Review 4.  An emerging link between LIM domain proteins and nuclear receptors.

Authors:  Stefano Sala; Christophe Ampe
Journal:  Cell Mol Life Sci       Date:  2018-02-10       Impact factor: 9.261

Review 5.  Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.

Authors:  Masaki Shiota; Masatoshi Eto
Journal:  Int J Urol       Date:  2016-04-08       Impact factor: 3.369

Review 6.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

Review 7.  The nuclear receptor superfamily: A structural perspective.

Authors:  Emily R Weikum; Xu Liu; Eric A Ortlund
Journal:  Protein Sci       Date:  2018-11       Impact factor: 6.725

Review 8.  Hepatocellular carcinoma: From diagnosis to treatment.

Authors:  Miral Sadaria Grandhi; Amy K Kim; Sean M Ronnekleiv-Kelly; Ihab R Kamel; Mounes A Ghasebeh; Timothy M Pawlik
Journal:  Surg Oncol       Date:  2016-03-05       Impact factor: 3.279

Review 9.  Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.

Authors:  Enrico Garattini; Marco Bolis; Maurizio Gianni'; Gabriela Paroni; Maddalena Fratelli; Mineko Terao
Journal:  Oncotarget       Date:  2016-07-05

Review 10.  Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.

Authors:  Chuang Jiang; Gong Cheng; Mingheng Liao; Jiwei Huang
Journal:  World J Surg Oncol       Date:  2021-03-19       Impact factor: 2.754

View more
  4 in total

1.  Sex-specific changes in the expression of ER-alpha and androgen receptor with increasing tumor grade in patients with hepatocellular carcinoma.

Authors:  Caglar Berkel; Ercan Cacan
Journal:  Hum Cell       Date:  2022-03-29       Impact factor: 4.374

2.  A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.

Authors:  Yifeng Jin; Xiaofan Pu; Dongnan Ping; Chaojie Huang; Guoping Ding; Liping Cao
Journal:  World J Surg Oncol       Date:  2022-06-03       Impact factor: 3.253

3.  Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma.

Authors:  Baifeng Qian; Haozhong Lin; Tian Lan; Muqi Li; Xiwen Wu; Shuirong Lin; Zimin Song; Shunli Shen; Baogang Peng
Journal:  World J Surg Oncol       Date:  2022-08-05       Impact factor: 3.253

4.  Autophagy characteristics and establishment of autophagy prognostic models in lung adenocarcinoma and lung squamous cell carcinoma.

Authors:  Zhubei Chen; Hui Xiong; Hao Shen; Qingsheng You
Journal:  PLoS One       Date:  2022-03-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.